《柳叶刀神经杂志2025》修正；24: 279 - 81

The Lancet Neurology Pub Date : 2025-04-17 DOI:10.1016/s1474-4422(25)00148-6

{"title":"《柳叶刀神经杂志2025》修正；24: 279 - 81","authors":"","doi":"10.1016/s1474-4422(25)00148-6","DOIUrl":null,"url":null,"abstract":"Schott JM. Amyloid immunotherapy to prevent Alzheimer's disease: the wrong drug at the right time? Lancet Neurol 2025; 24: 279–81—In this Comment, the analyses of 22 asymptomatic individuals has been changed to prespecified in paragraph seven. This correction has been made to the online version as of April 17, 2025.","PeriodicalId":22676,"journal":{"name":"The Lancet Neurology","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to Lancet Neurol 2025; 24: 279–81\",\"authors\":\"\",\"doi\":\"10.1016/s1474-4422(25)00148-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Schott JM. Amyloid immunotherapy to prevent Alzheimer's disease: the wrong drug at the right time? Lancet Neurol 2025; 24: 279–81—In this Comment, the analyses of 22 asymptomatic individuals has been changed to prespecified in paragraph seven. This correction has been made to the online version as of April 17, 2025.\",\"PeriodicalId\":22676,\"journal\":{\"name\":\"The Lancet Neurology\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet Neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s1474-4422(25)00148-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s1474-4422(25)00148-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

Schott JM。淀粉样蛋白免疫疗法预防阿尔茨海默病：在正确的时间使用错误的药物？柳叶刀神经杂志2025；[24:279 - 81]在本评论中，对22名无症状个体的分析已更改为第7段预先规定的。此更正已于2025年4月17日对在线版本进行了修改。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to Lancet Neurol 2025; 24: 279–81

Schott JM. Amyloid immunotherapy to prevent Alzheimer's disease: the wrong drug at the right time? Lancet Neurol 2025; 24: 279–81—In this Comment, the analyses of 22 asymptomatic individuals has been changed to prespecified in paragraph seven. This correction has been made to the online version as of April 17, 2025.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Lancet Neurology

自引率

0.00%

发文量